Skip to main content
Log in

News from ISTH

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Maly J, Dulicek P, Pecka M, Vodickova L, Maly R.Confirmation of efficacy, safety and cost effectiveness of Fraxiparine (Rm) forte in the outpatient treatment of deep venous thrombosis. 21st Congress of the International Society on Thrombosis and Haemostasis: abstr. P-T-518, 6 Jul 2007. Available from: URL: http://www.isth2007.com

  2. Bonnet P, Yoon B, Ewenstein B, Wong W.Cost-effectiveness of activated prothrombin complex concentrate vs. recombinant FVIIA in prophylaxis in hemophilia patients with inhibitors. 21st Congress of the International Society on Thrombosis and Haemostasis: abstr. P-M-168, 6 Jul 2007. Available from: URL: http://www.isth2007.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

News from ISTH. Pharmacoecon. Outcomes News 535, 12 (2007). https://doi.org/10.2165/00151234-200705350-00029

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705350-00029

Keywords

Navigation